Omniose is an early stage biotechnological company.
Omniose has raised $3.0M in total funding. The most recent round was Grant. The last funding was announced in September 2023.
Omniose's investors include National Institutes of Health, Arch Grants, BioGenerator, National Institute of Allergy and Infectious Diseases.
Omniose is headquartered in St Louis, United States.
Omniose is an early stage biotechnological company.
Omniose is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Omniose — Funding & Investors." VCBacked, September 27, 2023, https://www.vcbacked.co/company/omniose. Accessed July 20, 2026.
VCBacked. (2023). Omniose — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/omniose
{{cite web |title=Omniose — Funding & Investors |url=https://www.vcbacked.co/company/omniose |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated